February 27, 2019
"Structure-based Design of Novel Kinase Inhibitors and Compounds that Re-activate Mutant p53"
John Karanicolas, Ph.D.
Associate Professor, Molecular Therapeutics
Fox Chase Cancer Center, Philadelphia, PA
Host: Dr. John Chodera
Tea: 10:15 a.m.